SVF 001
Alternative Names: SVF-001Latest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator Svenska VaccinFabriken
- Class Hepatitis B vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B; Hepatitis D
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for preclinical development in Hepatitis-B in Sweden (Parenteral)
- 28 Nov 2024 No recent reports of development identified for preclinical development in Hepatitis-D in Sweden (Parenteral)
- 21 Oct 2020 Preclinical trials in Hepatitis B in Sweden (Parenteral)